Echo Therapeutics, Inc.
ECTE
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $3.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.98 |
| Beta | 6.78 |
| Outstanding Shares | 11,604,000 |
Return
| Return on Equity | 96.14% |
|---|---|
| Return on Assets | -561.45% |
| Return on Invested Capital | 92.94% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.58 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.05 |
| Debt to Equity | -0.56 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Echo Therapeutics, Inc.
19 employees
CEO: Mr. Alan W. Schoenbart CPA Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a...